SJ25C1）（PerCP/Cy5.5 Recombinant Anti-human CD19 Monoclonal Antibody (Clone: SJ25C1)）用冰袋运输。收到后，请立即将其存放在下面建议的温度下。 稳定性与存储 ...

The anti-CD19 mAb conjugated to a mayatansine derivative SAR3419, the anti-B cell lactosamine mAb mAref-216 and the anti-CD37 IgG fusion protein TRU-016 may be promising reagents for pediatric B ...

Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal ...

The second ADC, SGN-CD19A (Seattle Genetics), comprises a humanized anti-CD19 monoclonal antibody conjugated with MMAF using the noncleavable MC, which is the same linker–cytotoxic agent ...

Climb Bio has entered an exclusive licence agreement with Beijing Mabworks Biotech for developing and commercialising the ...

USA-based Climb Bio said yesterday it has entered into an exclusive license agreement with Beijing Mabworks Biotech for ...